Cargando…

First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites

BACKGROUND: Much effort is being devoted for developing new indicators to evaluate the human exposure to Aedes mosquito bites and the risk of arbovirus transmission. Human antibody (Ab) responses to mosquito salivary components could represent a promising tool for evaluating the human-vector contact...

Descripción completa

Detalles Bibliográficos
Autores principales: Elanga Ndille, Emmanuel, Doucoure, Souleymane, Damien, Georgia, Mouchet, François, Drame, Papa Makhtar, Cornelie, Sylvie, Noukpo, Herbert, Yamadjako, Sandra, Djenontin, Armel, Moiroux, Nicolas, Misse, Dorothee, Akogbeto, Martin, Corbel, Vincent, Henry, Marie-Claire, Chandre, Fabrice, Baldet, Thierry, Remoue, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499371/
https://www.ncbi.nlm.nih.gov/pubmed/23166852
http://dx.doi.org/10.1371/journal.pntd.0001905
_version_ 1782249949924163584
author Elanga Ndille, Emmanuel
Doucoure, Souleymane
Damien, Georgia
Mouchet, François
Drame, Papa Makhtar
Cornelie, Sylvie
Noukpo, Herbert
Yamadjako, Sandra
Djenontin, Armel
Moiroux, Nicolas
Misse, Dorothee
Akogbeto, Martin
Corbel, Vincent
Henry, Marie-Claire
Chandre, Fabrice
Baldet, Thierry
Remoue, Franck
author_facet Elanga Ndille, Emmanuel
Doucoure, Souleymane
Damien, Georgia
Mouchet, François
Drame, Papa Makhtar
Cornelie, Sylvie
Noukpo, Herbert
Yamadjako, Sandra
Djenontin, Armel
Moiroux, Nicolas
Misse, Dorothee
Akogbeto, Martin
Corbel, Vincent
Henry, Marie-Claire
Chandre, Fabrice
Baldet, Thierry
Remoue, Franck
author_sort Elanga Ndille, Emmanuel
collection PubMed
description BACKGROUND: Much effort is being devoted for developing new indicators to evaluate the human exposure to Aedes mosquito bites and the risk of arbovirus transmission. Human antibody (Ab) responses to mosquito salivary components could represent a promising tool for evaluating the human-vector contact. METHODOLOGY/PRINCIPAL FINDINGS: To develop a specific biomarker of human exposure to Aedes aegypti bites, we measured IgG Ab response to Ae. aegypti Nterm-34 kDa salivary peptide in exposed children in 7 villages of Southern Benin (West Africa). Results showed that specific IgG response presented high inter-individual heterogeneity between villages. IgG response was associated with rainfall and IgG level increased from dry (low exposure) to rainy (high exposure) seasons. These findings indicate that IgG Ab to Nterm-34 kDa salivary peptide may represent a reliable biomarker to detect variation in human exposure to Ae. aegypti bites. CONCLUSION/SIGNIFICANCE: This preliminary study highlights the potential use of Ab response to this salivary peptide for evaluating human exposure to Ae. aegypti. This biomarker could represent a new promising tool for assessing the risk of arbovirus transmission and for evaluating the efficacy of vector control interventions.
format Online
Article
Text
id pubmed-3499371
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34993712012-11-19 First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites Elanga Ndille, Emmanuel Doucoure, Souleymane Damien, Georgia Mouchet, François Drame, Papa Makhtar Cornelie, Sylvie Noukpo, Herbert Yamadjako, Sandra Djenontin, Armel Moiroux, Nicolas Misse, Dorothee Akogbeto, Martin Corbel, Vincent Henry, Marie-Claire Chandre, Fabrice Baldet, Thierry Remoue, Franck PLoS Negl Trop Dis Research Article BACKGROUND: Much effort is being devoted for developing new indicators to evaluate the human exposure to Aedes mosquito bites and the risk of arbovirus transmission. Human antibody (Ab) responses to mosquito salivary components could represent a promising tool for evaluating the human-vector contact. METHODOLOGY/PRINCIPAL FINDINGS: To develop a specific biomarker of human exposure to Aedes aegypti bites, we measured IgG Ab response to Ae. aegypti Nterm-34 kDa salivary peptide in exposed children in 7 villages of Southern Benin (West Africa). Results showed that specific IgG response presented high inter-individual heterogeneity between villages. IgG response was associated with rainfall and IgG level increased from dry (low exposure) to rainy (high exposure) seasons. These findings indicate that IgG Ab to Nterm-34 kDa salivary peptide may represent a reliable biomarker to detect variation in human exposure to Ae. aegypti bites. CONCLUSION/SIGNIFICANCE: This preliminary study highlights the potential use of Ab response to this salivary peptide for evaluating human exposure to Ae. aegypti. This biomarker could represent a new promising tool for assessing the risk of arbovirus transmission and for evaluating the efficacy of vector control interventions. Public Library of Science 2012-11-15 /pmc/articles/PMC3499371/ /pubmed/23166852 http://dx.doi.org/10.1371/journal.pntd.0001905 Text en © 2012 Elanga Ndille et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Elanga Ndille, Emmanuel
Doucoure, Souleymane
Damien, Georgia
Mouchet, François
Drame, Papa Makhtar
Cornelie, Sylvie
Noukpo, Herbert
Yamadjako, Sandra
Djenontin, Armel
Moiroux, Nicolas
Misse, Dorothee
Akogbeto, Martin
Corbel, Vincent
Henry, Marie-Claire
Chandre, Fabrice
Baldet, Thierry
Remoue, Franck
First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
title First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
title_full First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
title_fullStr First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
title_full_unstemmed First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
title_short First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
title_sort first attempt to validate human igg antibody response to nterm-34kda salivary peptide as biomarker for evaluating exposure to aedes aegypti bites
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499371/
https://www.ncbi.nlm.nih.gov/pubmed/23166852
http://dx.doi.org/10.1371/journal.pntd.0001905
work_keys_str_mv AT elangandilleemmanuel firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT doucouresouleymane firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT damiengeorgia firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT mouchetfrancois firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT dramepapamakhtar firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT corneliesylvie firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT noukpoherbert firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT yamadjakosandra firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT djenontinarmel firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT moirouxnicolas firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT missedorothee firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT akogbetomartin firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT corbelvincent firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT henrymarieclaire firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT chandrefabrice firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT baldetthierry firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites
AT remouefranck firstattempttovalidatehumaniggantibodyresponsetonterm34kdasalivarypeptideasbiomarkerforevaluatingexposuretoaedesaegyptibites